NLS Collaboration

Agreement - February 23, 2023

AstraZeneca enters license agreement with KYM Biosciences

The companies have entered into a global exclusive license agreement for CMG901, a potential first-in-class antibody drug conjugate (ADC) targeting Claudin 18.2, a promising therapeutic target in gastric cancer. Under the licence agreement, AstraZeneca will be responsible for the research, development, manufacture and commercialisation of CMG901 globally. CMG901 CMG901 is currently being evaluated in a […]

Agreement - January 17, 2023

Bristol Myers Squibb and Karolinska University Hospital enter collaboration

Karolinska University Hospital’s cancer department has signed an agreement with Bristol Myers Squibb to start an oncology and hematology research collaboration focusing on advancing research and generating data with an aim to deliver innovative therapies for patients. The organizations will centralize the work through a steering committee consisting of experts from both organizations to discuss […]

Agreement - January 10, 2023

CombiGene and Zyneyro enter collaboration agreement

The two companies have entered into a collaboration agreement regarding the continued development of Zyneyro’s peptide- and AAV-based treatment of chronic pain conditions. The agreement with Zyneyro is a cooperation agreement that means that Zyneyro and CombiGene share the project’s costs and revenues equally. “The concept of being able to give the pain-relieving peptide directly […]

Collaboration - January 7, 2023

She is the new Director General of SwedenBIO

SwedenBIO has appointed the co-founder and operational manager of Sprint Bioscience, Jessica Martinsson, as its new Director General. “With her entrepreneurial experience and co-founder of a life science company, SwedenBIO will gain a leadership that will drive the industry’s development further. Jessica’s knowledge within drug development in both small and large companies as well as […]

Collaboration - December 21, 2022

Season’s Greetings from Nordic Life Science

We would like to thank our readers, subscribers and collaboration partners for a fruitful 2022, and we wish you all a most wonderful holiday season! 2022 has been – yet another – challenging year and we have reported about how it is to work from Ukraine and how our industry is affected by the uncertain […]

Collaboration - December 19, 2022

Highlights from SALSS’s Science4Peace Summit

The Science4Peace Summit, a manifestation of the Swedish American Life Science Summit (SALSS) together with The Galien Foundation, took place in Stockholm on the 12th of December during the Nobel festivities. Barbro Ehnbom, the founder of SALSS, and her team had invited dignitaries in science, life science and healthcare to participate in a manifestation for […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.